Bristol Myers Squibb Is A Good Dividend Stock: Should You Buy?

Of the 236 stocks in the Medical – Pharmaceuticals industry, BMY is ranked #14. In total, we rate BMY in eight different levels. Beyond what we’ve stated, one  can get additional BMY Ratings for Momentum, Quality, and Stability here.

Check out the top-rated stocks in the Medical – Pharmaceuticals industry here.

Bottom Line

As the Fed continues to hold interest rates at near zero levels, we think BMY is an ideal stock for a steady stream of income. Also, the company’s impressive progress in drug development could soon translate to substantial price appreciation.

BMY shares were trading at $63.24 per share on Thursday afternoon, up $0.11 (+0.17%). Year-to-date, BMY has gained 2.75%, versus a 7.20% rise in the benchmark S&P 500 index during the same period.

Want More Great Investing Ideas?

“MUST OWN” Growth Stocks for 2021

How to Ride the NEW Stock Bubble?

5 WINNING Stocks Chart Patterns

Unlock the POWR in Your Portfolio!

1 2 3
View single page >> |

Disclaimer: Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.
Roger Keats 1 month ago Member's comment

so we buy and hold